Literature DB >> 2967435

The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria.

P Selvaraj1, W F Rosse, R Silber, T A Springer.   

Abstract

Fc receptors on phagocytic cells in the blood mediate binding and clearance of immune complexes, phagocytosis of antibody-opsonized microorganisms, and potently trigger effector functions, including superoxide anion production and antibody-dependent cellular cytotoxicity. The Fc receptor type III (Fc gamma R III, CD 16), present in 135,000 sites per cell 1 on neutrophils and accounting for most of FcR in blood, unexpectedly has a phosphatidylinositol glycan (PIG) membrane anchor. Deficiency of Fc gamma R III is observed in paroxysmal nocturnal haemoglobinuria (PNH), an acquired abnormality of haematopoietic cells affecting PIG tail biosynthesis or attachment, and is probably responsible for circulating immune complexes and susceptibility to bacterial infections associated with this disease. Although a growing number of eukaryotic cell-surface proteins with PIG-tails are being described, none has thus far been implicated in receptor-mediated endocytosis or in triggering of cell-mediated killing. Our findings on the Fc gamma R III raise the question of how a PIG-tailed protein important in immune complex clearance in vivo and in antibody-dependent killing mediates ligand internalization and cytotoxicity. Together with our results, previous functional studies on Fc gamma R III and Fc gamma R II suggest that these two receptors may cooperate and that the type of membrane anchor is an important mechanism whereby the functional capacity of surface receptors can be regulated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967435     DOI: 10.1038/333565a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  96 in total

1.  Analysis of competition binding between soluble and membrane-bound ligands for cell surface receptors.

Authors:  P Li; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Concurrent and independent binding of Fcgamma receptors IIa and IIIb to surface-bound IgG.

Authors:  T E Williams; S Nagarajan; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Concurrent binding to multiple ligands: kinetic rates of CD16b for membrane-bound IgG1 and IgG2.

Authors:  T E Williams; P Selvaraj; C Zhu
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

Review 4.  Functions of the Fc receptors for immunoglobulin G.

Authors:  B K Flesch; J Neppert
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

5.  Neutrophils from the synovial fluid of patients with rheumatoid arthritis express the high affinity immunoglobulin G receptor, Fc gamma RI (CD64): role of immune complexes and cytokines in induction of receptor expression.

Authors:  J A Quayle; F Watson; R C Bucknall; S W Edwards
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

Review 6.  Murine soluble Fc gamma receptors/IgG-binding factors (IgG-BF): analysis of the relation to Fc gamma RII and production of milligram quantities of biologically active recombinant IgG-BF.

Authors:  C Sautès; N Mazières; A Galinha; E Tartour; C Bonnerot; S Amigorena; C Teillaud; R Spagnoli; W H Fridman
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 7.  Function and heterogeneity of human Fc receptors for immunoglobulin G.

Authors:  J C Unkeless
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

8.  A human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored forms.

Authors:  B J Scallon; E Scigliano; V H Freedman; M C Miedel; Y C Pan; J C Unkeless; J P Kochan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

9.  Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.

Authors:  Rangaiah Shashidharamurthy; Fang Zhang; Aaron Amano; Aparna Kamat; Ravichandran Panchanathan; Daniel Ezekwudo; Cheng Zhu; Periasamy Selvaraj
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

10.  Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80).

Authors:  R S McHugh; S N Ahmed; Y C Wang; K W Sell; P Selvaraj
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.